Improving the odds of drug development success through human genomics: modelling study
Aroon D Hingorani
Felix A Kruger
Raymond J MacAllister
John P Overington
Flipping the odds of drug development success through human genomics
How to estimate the association between change in a risk factor and a health outcome?
Estimating the effect of reduced attendance at emergency departments for suspected cardiac conditions on cardiac mortality during the COVID-19 pandemic
A national initiative in data science for health: an evaluation of the UK Farr Institute
A semi-supervised approach for rapidly creating clinical biomarker phenotypes in the UK Biobank using different primary care EHR and clinical terminology systems.